De beoordeling van nieuwe geneesmiddelen. Article in Pharmaceutisch weekblad 3(1) Henk Buurma at Independent Researcher. Henk Buurma. Buy Het juiste medicijn: ruim geneesmiddelen kritisch beoordeeld 01 by Marcel Bouvy, Henk Buurma (ISBN: ) from Amazon’s Book Store. Buurma, H., Jong-van den Berg, L.T.W. de, Leufkens, H.G.M., Het geneesmiddel, Wetenschappelijke uitgeverij Bunge, Utrecht Callon, M, Law, J., Rip, A.
|Published (Last):||17 July 2012|
|PDF File Size:||6.67 Mb|
|ePub File Size:||5.95 Mb|
|Price:||Free* [*Free Regsitration Required]|
Cost-effectiveness of statins for primary prevention in newly diagnosed type 2 diabetes patients: Assessment of new cardiovascular drugs: Scope and nature of prescribing decisions made by general practitioners Denig, P.
The value of clinical judgement analysis for improving the quality of doctors’ prescribing decisions Denig, P. Verbetering blijft nog uit Denig, P.
prof. dr. P. (Petra) Denig
Claims in advertisements for antihypertensive drugs in a Dutch medical journal Greving, J. Healthcare quality improvement programme improves monitoring of people with diabetes Denig, Guurma. Cardiometabolic treatment decisions in patients with type 2 diabetes: Exploring differences in adherence to guidelines between gendesmiddel European countries Veninga, C.
Reasons of general practitioners for not prescribing lipid-lowering medication to geneesmiddrl with diabetes: Faculty of Medical Sciences. Comparison of various measures for assessing medication refill adherence using prescription data Vink, N. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: Identification of major cardiovascular events in patients with diabetes using primary care data Pouwels, K.
Development of a minimal set of prescribing quality indicators for diabetes management on a general practice level Martirosyan, L. Coping with adverse drug events in patients with heart failure: Long-term exposure to anticholinergic and sedative drugs and cognitive and physical function in later life Wouters, H. The impact of new insights and revised practice guidelines on prescribing drugs in the treatment of type 2 diabetes mellitus Lub, R.
International Geneesmiiddel of Nursing Studies.
Physician, organizational, and patient factors associated with suboptimal blood pressure mManagement in Type 2 diabetic patients in primary care Schaars, C.
Self-reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: Amsterdam Medical Pressp. Communication on Safety of Medicines in Europe: BMJ Clinical research ed. A matched cohort design De Vries, F.
Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Journal of Internal Medicine.
There was a problem providing the content you requested
British Journal of Clinical Pharmacology. Apotheker wordt beter zichtbaar voor medicijngebruiker Crutzen, S. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands de Vries, F. The decision process of the physician Denig, P.
Petra Denig – Research database – University of Groningen
Nederlands Tijdschrift voor Diabetologie. A systematic review of measures estimates adherence and persistence to multiple medications Alfian, S.
Gender differences in drug-Adverse drug reaction combinations reported to the national pharmacovigilance centre in the Netherlands de Vries, S.
Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: Prescribing quality and indicators.